These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7520802)

  • 1. Selective rubella vaccination programmes: a survey of districts in England and Wales.
    Gay NJ; Valambia S; Galasko D; Miller E
    Commun Dis Rep CDR Rev; 1994 Jun; 4(7):R77-9. PubMed ID: 7520802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measles/rubella immunisation campaign in Scotland.
    Skinner R; Christie P; Cowden JM
    Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-rubella vaccine coverage in women 11-28 years of age: data on 5 local socio-health units of Veneto].
    Maggiore A; Cinquetti S; Todescato A; Schibuola G; Schiavello R; De Noni L; Collareta AL; Giacobbo M; Perini G; Grandolfo M
    Epidemiol Prev; 1992 Jun; 14(51):20-4. PubMed ID: 1345011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has the United States population been adequately vaccinated to achieve rubella elimination?
    Bloom S; Smith P; Stanwyck C; Stokley S
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S141-5. PubMed ID: 16998773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
    Robertson SE; Cutts FT; Samuel R; Diaz-Ortega JL
    Bull World Health Organ; 1997; 75(1):69-80. PubMed ID: 9141752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of US hospitals on recommended screening and immunization practices for pregnant and postpartum women.
    Bath SK; Singleton JA; Strikas RA; Stevenson JM; McDonald LL; Williams WW
    Am J Infect Control; 2000 Oct; 28(5):327-32. PubMed ID: 11029130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of rubella since the MR vaccination campaign.
    Commun Dis Rep CDR Wkly; 1995 Apr; 5(17):81. PubMed ID: 7749459
    [No Abstract]   [Full Text] [Related]  

  • 9. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females.
    Gudmundsdóttir S; Antonsdóttir A; Gudnadóttir S; Elefsen S; Einarsdóttir B; Olafsson O; Gudnadóttir M
    Bull World Health Organ; 1985; 63(1):83-92. PubMed ID: 3872738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Tookey P; Morgan-Capner P; Hesketh L; Brown D; Waight P; Vurdien J; Jones G; Peckham C
    Commun Dis Rep CDR Rev; 1994 Nov; 4(12):R146-52. PubMed ID: 7529090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunisation coordinator: improving uptake of childhood immunisation.
    Crittenden P; Rao M
    Commun Dis Rep CDR Rev; 1994 Jun; 4(7):R79-81. PubMed ID: 7520803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of adolescent vaccination programmes through school.
    Knops J; Hoppenbrouwers K; Roelants M; Vandermeulen C
    Biologicals; 1997 Jun; 25(2):155-7. PubMed ID: 9236044
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential for measles transmission in England.
    Choi YH; Gay N; Fraser G; Ramsay M
    BMC Public Health; 2008 Sep; 8():338. PubMed ID: 18822142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of different vaccination programmes to prevent congenital rubella.
    Stray-Pedersen B
    NIPH Ann; 1982 Dec; 5(2):69-83. PubMed ID: 6820478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer assessment of alternative rubella vaccination strategies in New Zealand.
    Riseley RC; Smith AH; Laugesen M; Chapman CJ
    N Z Med J; 1983 Apr; 96(729):235-8. PubMed ID: 6572834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the impact of childhood influenza vaccination programmes in England and Wales.
    Vynnycky E; Pitman R; Siddiqui R; Gay N; Edmunds WJ
    Vaccine; 2008 Sep; 26(41):5321-30. PubMed ID: 18647634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
    Wang IJ; Huang LM; Chen HH; Hwang KC; Chen CJ
    J Med Virol; 2007 Jan; 79(1):97-103. PubMed ID: 17133552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.